Bromide

Bromide

SCHEMBL6981265

O=C(O)Cn1cccn1.[Br-].[H+]

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.43
HTT P42858 1/20 0.42
TSHR P16473 2/20 0.41
GLS O94925 2/20 0.40
ALDH1A1 P00352 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
BRD4 O60885 1/20 0.35
KDM5A P29375 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1073206 0.96
Bromide SCHEMBL6981267 0.94 FDPS (0.44) FDPSHTTTSHRGLSALDH1A1
Hydrochloric Acid SCHEMBL8893774 0.94 FDPS (0.44) FDPSHTTTSHRGLSALDH1A1
Trifluoroacetic Acid SCHEMBL29488711 0.85 HTT (0.39) FDPSHTTTSHRGLSALDH1A1
SCHEMBL1178867 0.77
SCHEMBL8893769 0.77
SCHEMBL11971222 0.77
SCHEMBL4663218 0.75 EGLN3 (0.50) FDPSHTTTSHRKMT2AKDM5A
Hydrochloric Acid SCHEMBL11248094 0.75 FDPS (0.43) FDPSHTTTSHRGLSHDAC1
Hydrochloric Acid SCHEMBL1499316 0.75 FDPS (0.43) FDPSHTTTSHRGLSHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed